Apoptosis induced by modified ribonucleosides in human cell culture systems  by Meisel, Hans et al.
FEBS 20689 FEBS Letters 433 (1998) 265 268 
Apoptosis induced by modified ribonucleosides 
in human cell culture systems 
Hans Meisel*, Sonja Gtinther, Dierk Martin, Eckhard Schlimme 
Bundesanstalt J~ir MilchJbrschung, lnstitut fiir Chemie und Physik, Post]kwh 6069, D-24121 Kiel, Germany 
Received 29 June 1998; revised version received 16 July 1998 
Abstract The in vitro modulation of apoptosis and cell 
proliferation by modified in comparison with non-modified 
ribonucleosides was investigated for the first time using 
peripheral blood lymphoeytes, HL-60 cells and Caco-2 cells as 
human cell culture models. Modulating effects of several 
ribonucleosides were found in the range of 10-~-10 s mol/i. 
The following ribonuclensides induced significant apoptosis of 
HL-60 cells: adenosine, N6-dimethyladenosine, N~-(2-isopente - 
nyl)-adenosine, N2-dimethylguanosine. A significant apoptotic 
effect on PBL was found with N6-dimethyladenosine and N°-(2 - 
isopentenyl)-adenosine. N6-Dimethyladenosine, N6-(2-isopente - 
nyl)-adenosine and guanosine had a pronounced inhibitory effect 
on Caco-2 cell apoptosis. Regarding the known function of 
ribonucleosides as pathobiochemical marker molecules for 
cancer, the possibility of a selective apoptotic effect against 
malignant cells is discussed. 
© 1998 Federation of European Biochemical Societies. 
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1. Introduction 
Besides their central role as monomeric omponents of nu- 
cleic acids, nucleos(t)ides and nucleobases have several regu- 
latory functions (for review: [1,2]), e.g. they affect immune 
modulation, contribute to iron absorption in the gut and in- 
fluence desaturation and elongation rates in fatty acid syn- 
thesis. Apart  from these bio- and trophochemical properties, 
ribonucleosides can influence the activity of cells due to their 
translocation across the plasma membrane [3] by specified 
facilitated-diffusion carriers and sodium-dependent transloca- 
tors [3 6] located in intestinal and kidney epithelial cells [7,8]. 
Modified ribonucleosides excreted in higher amounts in the 
urine of cancer patients could serve as pathobiochemical 
marker molecules for different ypes of cancer diseases [9 12]. 
Although there is growing interest in the role of apoptosis 
in cancer, the possible involvement of modified ribonucleo- 
sides as signals that can trigger apoptosis of cancer cells has 
not yet been investigated. Apoptosis is a type of cell death 
exhibiting a distinct set of morphological and biochemical 
changes (for review: [13]). Deficient apoptosis can promote 
tumorigenesis, both by allowing the accumulation of dividing 
cells and by not removing cells with genetic lesions [14]. In 
this study, the modulat ion of apoptosis and cell proliferation 
by different ribonucleosides i  described in human cell culture 
models. Differences are apparent for the apoptotic effect of 
modified compared to non-modif ied ribonucleosides. 
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2. Materials and methods 
2.1. Ribonueleosides 
N6-Carbamoyl-threonyladenosine (t6ado) was synthesized accord- 
ing to [15]; N~-dimethylguanosine (m2,2guo) was a gift from K.-P. 
Raezke (Applica GmbH, Bremen, Germany). All other ribonucleo- 
sides such as adenosine (ado), Nl-methyladenosine (mlado), N6-meth - 
yladenosine (m6ado), N%dimethyladenosine (m6,2ado), Afi-(2-isopen- 
tenyl)-adenosine (ip6ado), N2-dimethylguanosine (m2,2guo), N 7- 
methylguanosine (m7guo), inosine (ino), Nl-methylinosine (mlino), 
NT-methylinosine (m7ino), cytidine (cyd) and uridine (urd) were ob- 
tained from Sigma-Aldrich Chemie GmbH, Deisenhofen, Germany. 
The ribonucleoside content in different preparations as well as in 
culture media was analyzed by HPLC as described in [16] using a 
photodiode array detector. Ribonucleoside preparations with a purity 
of > 99% were used for cell chemical analyses. 
2.2. Cells and culture conditions 
Human peripheral blood lymphocytes (PBL) were isolated from 
heparin-treated blood of healthy human volunteers by density gra- 
dient centrifugation method as described [I7]. HL-60 cells (promyelo- 
cytic leukemia, human) were from the American Type Culture Col- 
lection, Rockville, MD, USA (ATCC CCL-240) and Caco-2 cells 
from DSMZ-German Collection of Microorganisms and Cell Cul- 
tures, Braunschweig, Germany (DSM ACC 169). Cells were routinely 
grown in 25 cm 2 plastic flasks (Sigma-Aldrich Chemie GmbH, Dei- 
senhofen, Germany) at 37°C in an atmosphere of 5% CO2. PBL and 
HL-60 cells were maintained in suspension culture in a low protein 
medium HL-I (BioWhittaker Inc., Walkersville, USA) supplemented 
with 0.5% heat-inactivated f tal calf serum (FCS; Sigma-Aldrich) and 
2 mmol/1 L-glutamine. Caco-2 cells were cultured in Dulbecco's modi- 
fied Eagle medium (DMEM; Sigma-Aldrich) with 4.5 g/l glucose sup- 
plemented with 20% FCS and 4 mmol/1 L-glutamine. All culture media 
contained 100 U/ml penicillin and I00 lag/ml of streptomycin (Sigma- 
Aldrich). HL-60 cells were seeded at IX 10 s cells/ml and were pas- 
saged every 34  days. 
Caco-2 cells plated at 1 x 104 cells/cm 2 were passaged every 45  
days when confluence was reached; medium was changed every 2 
days. The Caco-2 monolayer was dissociated using 0.05% trypsin- 
0.02% EDTA solution in Hanks' balanced salt solution (HBSS; Sig- 
ma-Aldrich). HL-60 and Caco-2 cells were used between passage num- 
bers 10 and 40. 
Cell number was determined with a cell counter (Casy 1, Sch~irfe 
System, Reutlingen, Germany) based on conductivity measurement. 
Cells with more than 90% viability as assessed by the trypan blue dye 
exclusion test were used for analyses. 
2.3. Measurement of proliferation and apoptosis 
For quantitative immunoassays, cells were seeded in a 96-well mi- 
crotiter plate at densities of 1 x 10 a cells/well and 2X l0 s (only pro- 
liferation of PBL), respectively. After plating, Caco-2 cells were al- 
lowed to grow to 40 50% confluence (1 day). PBL and HL~60 cells 
were incubated with various concentrations of an individual ribonu- 
cleoside (10-11 10 -:~ mol/l) for 4 h (apoptosis) or 72 h (proliferation); 
the respective incubation times of Caco-2 cells were 24 and 55 h. Each 
treatment was replicated in five wells for proliferation and three wells 
for apoptosis. 
Proliferation changes were measured as described in [17] using a 
colorimetric enzyme immunoassay (Boehringer Mannheim, Germany, 
kit 1647229) based on incorporation of 5-bromo-2'-deoxyuridine 
(BrdU) during DNA synthesis within 17 h (Caco-2) or 24 h (PBL, 
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HL-60). Results were read out on an ELISA spectrophotometer (An- 
thos HT-2) at 450 nm (reference wavelength: 620 nm). 
Apoptosis was determined using a photometric immunoassay 
(Boehringer Mannheim, kit 1774425) which is based on the determi- 
nation of histone-associated DNA fragments in the cytoplasmic frac- 
tion of cell lysates [18,19]. To distinguish apoptosis from necrosis, 
culture supernatant was checked simultaneously for the presence of 
DNA fragments. The assay was performed using monoclonal anti- 
bodies against DNA and histones, respectively, for the specific deter- 
mination of mono- and oligonucleosomes according to the manufac- 
turer's protocol, and results were read out on an ELISA 
spectrophotometer at 405 nm against substrate solution as a blank 
(reference wavelength: 492 nm). 
For light microscope detection of apoptosis at single cell level the 
annexin V method [20] was used to detect he translocation of phos- 
phatidylserine to the external surface of the plasma membrane with an 
annexin-V-biotin probe. After treatment with 10 -3 mol/l ribonucleo- 
side, 1 x 10 ~ PBL or HL-60 cells were incubated in 100 lal annexin-V- 
biotin working solution (Boehringer Mannheim) in HEPES buffer 
(Sigma-Aldrich) for 10 min and washed two times. Cells were then 
resuspended in 0.4 ml HEPES buffer, 0.2 ml of which was transferred 
into a 0.75 ml cyto-container (Zyto-System, Heraeus) and centrifuged 
onto a slide (600 rpm, 5 min). Cells were fixed with methanol/ethanol 
(1:1, v/v), incubated in 100 pl streptavidin-POD working solution 
(Boehringer Mannheim) in HEPES buffer for 1 h, rinsed with HEPES 
buffer and finally incubated with DAB (diaminobenzidine) substrate 
solution in peroxide buffer (1+9, v/v) (Boehringer Mannheim) for 10 
min. Apoptotic ceils were identified by direct visualization of brown- 
colored membrane staining under a light microscope. The dye exclu- 
sion test using trypan blue was performed simultaneously to discrim- 
inate between apoptosis and necrosis. 
Data analysis of immunoassays was performed using statistical soft- 
ware package StatMost (DataMost Corp., Salt Lake City, UT, USA). 
Comparisons of test vs. control absorbance measurements were made 
by Tukey's test where P < 0.05 was considered a significant difference 
of mean values. To compare the effects of different ribonucleosides, 
results were expressed as the increase and decrease, respectively, of cell 
activity in relation to control without ribonucleoside and calculated as 
(mean absorbancet~.Jmean absorbance~mt,ol). 
3. Results and discussion 
Attempts were made to grow cells under serum-reduced 
conditions and thus to avoid unwanted ribonucleoside impur- 
ities in media. Accordingly, PBL and HL-60, but not Caco-2 
cells, could be adapted to a lower serum concentration with- 
out any changes in cell viability. In Caco-2 media, 0.14-0.17 
~mol/1 ip6ado, t6ado, guo and 2.6-3.5 ~tmol/l cyd as well as 
urd were found. However, the amount  of impurities was neg- 
ligible in relation to the effective concentration of such test 
substances which induced a cell modulating effect. In prelimi- 
nary studies, cell number and incubation period with ribonu- 
cleosides were optimized to obtain a measurable modulating 
effect, i.e. to avoid too low or too high absorbance values. 
Compared with 24  h for induction of apoptosis in PBL and 
HL-60 cells, the apoptotic effect of Caco-2 cells was evident 
18-24 h after culturing in the presence of an apoptosis induc- 
ing ribonucleoside. 
Modulat ing effects of ribonucleosides were found in the 
range of 10-7-10 -:~ mol/1. The micromolar concentration 
was the most effective dosage of all ribonucleosides (Table 
1). Ado, m6ado, m6,2ado, ip6ado, and m2,2guo induced sig- 
nificant apoptosis of HL-60 cells accompanied by an inhibi- 
tion of proliferation. Several ribonucleosides inhibited PBL 
proliferation without a simultaneous stimulation of apoptosis 
but a significant apoptotic and antiproliferative effect on PBL 
was found with m6,2ado and ip6ado. Regarding Caco-2 cell 
activity, mlado,  m6ado, m6,2ado, ip6ado and guo had a pro- 
nounced effect as stimulants of apoptosis as well as inhibitors 
of proliferation; m2guo induced significant apoptosis of 
Caco-2 cells but proliferation remained unchanged. It was 
interesting to note that the antiproliferative effect, especially 
in HL-60, and to some extent the enhancement of apoptosis, 
revealed a relationship between increasing cell reactivity and 
the degree of chemical modification of the adenine moiety of 
ado (Fig. 1, Table 1). 
There is increasing evidence that apoptosis and necrosis 
represent he extreme ends of a wide range of possible mor- 
phological and biochemical deaths [21]. The two classical 
types of cell death can occur simultaneously in cell cultures 
exposed to the same stimulus. In this study, the mode of cell 
death induced by ado and several modified ribonucleosides 
was apoptotic. This was confirmed experimentally by the light 
Table 1 
Comparison of modulating effects of ribonucleosides (10 :~ mol/1) on cell proliferation and apoptosis 
based on BrdU incorporation and DNA fragmentation i  cell lysates, respectively 
assayed by quantitative immunoassays 
Ribonucleoside HL-60 PBL Caco-2 
Proliferation Apoptosis Proliferation Apoptosis Proliferation Apoptosis 
Ado 0.21 ***~ 4.91 *** 0.14"** 0.82 0.96 1.25 
ml Ado 0.07 ***t' 0.92 0.11 *** 0.72 0.72*** 1.37** 
m6Ado 0.17 **.1' 1.37"* 0.03 ***l' 0.87 0.61 *** 1.34"** 
m6,2Ado 0.00 ***~' 14.11 ***" 0.00***' 1.91 *** 0.01 ***~' 5.28*** 
ip6Ado 0.01"**" 21.90"**" 0.02 ***'j 2.43*** 0.01'**" 1.51 
t6Ado 0.92 1.18 1.34"** 0.73 0.96 1.08 
Guo 0.61 ** 2.00 0.36*** 0.83 0.89** 2.08"**" 
mlGuo 0.97 1.42 0.44*** 1.06 0.88*** 0.90 
m2Guo 1.24" 1.58 0.71 ** 0.98 1.01 1.31"* 
m2,2Guo 0.01"** 4.56*** 1.41"** 0.93 0.90** 0.88 
m7Guo 1.26 1.71 0.15*** 1.06 1.04 1.13 
Ino 1.09 1,22 1.35" 0.89 1.01 1.08 
m I lno 1.16 1,22 0.71 1.09 0.98 0.97 
m7Ino 0.75* 1.64 0.87 1.01 1.03 0.94 
Cyd 0.59 1.70 0.73 0.84 0.8 l*** 0.88 
Urd I. 17 1.23 0.90 0.98 0.87 0.97 
For details see Section 2.3. Results are expressed as the ratios test/control (mean absorbance~,~t/mean absorbance~.o,~tr,,1); 
stimulation: test/control > I, inhibition: test/control < 1. 
Mean values of measurements differ with *P < 0.05, **P < 0.01, ***P < 0.001. 
Significant effect already measurable at ribonucleoside concentration of "10 ~, hl0-q ' 10 ~, ,ll0 7 mol/l. 
~'Accompanied by significant necrosis based on the measurement of DNA fragments in cell culture supernatant (test/control = 1.55, P < 0.05). 
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Fig. 1. Effect of modified ribonucleosides ip6ado ([]), m6,2ado (O), 
m lado (v)  in comparison with ado (#) on incorporation of BrdU 
by human HL-60 cells. For details see Section 2.3. 
microscopic proof of translocation of phosphatidylserine to 
the outer layer of the cell membrane (PBL, HL-60) and the 
lack of DNA fragments in culture supernatant (PBL, HL-60, 
Caco-2). Martin et al. [22] have demonstrated that the phos- 
phatidylserine exposure is induced by a variety of apoptotic 
stimuli and occurs in a wide variety of cells. A significant 
amount of DNA fragments in culture supernatant which is 
indicative of the necrotic loss of cell membrane integrity and 
the leakage of cellular constituents into the cell environment 
[14] was found only with Caco-2 cells incubated with guo 
(Table 1). Similar to our findings in this study, Tanaka et 
al. [23] described the induction of apoptosis by ado (1 
mmol/1) in human HL-60 cells; the adenine moiety of ado 
was essential fbr its apoptosis-inducing activity. Furthermore, 
they found that ado acts at the intracellular level and that the 
effect was not mediated by ado receptors. 
We report for the first time on the in vitro modulation of 
apoptosis by modified ribonucleosides using human cell cul- 
ture models where the hypermodified m6,2ado and ip6ado 
showed the highest activity. The cancer cell lines Caco-2 
and HL-60 were more reactive to an apoptotic stimulation 
than non-malignant PBL. It is worth noting that most anti- 
cancer drugs produce apoptosis in sensitive ceils [24] involving 
an increased apoptotic response of cancerous cells and a min- 
imal response from normal cells. For example, micromolar 
concentrations of purine nucleoside analogues (2-chloro-2'-de- 
oxyadenosine, 9-[3-D-arabinosyl-2-fluoroadenine) are reported 
to be effective as apoptosis-inducing chemotherapeutic agents 
in the treatment of several types of leukemia, and it has been 
shown that their mechanisms of action implicate cellular sig- 
nalling networks [25]. 
Regarding the natural presence in living systems, modified 
ribonucleosides are mainly found in transfer RNA and orig- 
inate from cellular RNA breakdown. It is known that the 
pattern of these metabolic products is altered in body fluids 
of individuals uffering from neoplastic diseases, i.e. modified 
ribonucleosides serve as pathobiochemical marker molecules 
for cancer [9 12]. Because a vast majority of tumor promoters 
are potent inhibitors of apoptosis [26], it seems unlikely that 
cancer cells produce apoptosis-inducing ribonucleosides. It re- 
mains to be clarified if they are released by healthy cells as a 
reaction against malignant cells. However, this hypothesis is 
supported by our findings that cancer cell lines are reactive to 
apoptotic stimuli by modified ribonucleosides. 
Dietary nucleosides are ingested mainly as nucleoproteins 
and are converted in the course of intestinal digestion to 
monomeric ompounds. Ribonucleosides are in particular in- 
trinsic components of meat and meat products [27] but they 
are also available as minor food components especially in 
human and bovine milk [2,28-31]. Food-derived inducers of 
apoptosis may be of significance as exogenous anti-cancero- 
gens in the control of malignant cell proliferation where the 
intestinal tract could be the primary target site for a possible 
selective apoptotic stimuli against malignant cells. 
To generalize the conclusion from the present experiments, 
the biospecific sensing ability of living cells provides a tool for 
monitoring exogenous, e.g. dietary, bioactive substances. The 
mechanisms through which modified ribonucleosides exert 
their apoptotic and potential anticancerogenic effect are un- 
known. Further studies are now in progress, e.g. to measure 
the time-dependent utilization of ribonucleosides at the extra- 
and intracellular level, which may give insight into the molec- 
ular mechanisms underlying the apoptosis-inducing activities 
of modified ribonucleosides. 
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